Process for removing endogenous Vitamin B12 and folate from albumin preparations
View Patent ↗Processes for removing endogenous Vitamin B12 and folate are provided. The albumin preparations produced by the process are suitable for use as reference control samples in assays for determining these analytes in a test sample. Kits and methods related to the albumin preparations are also provided.
1. A process for removing endogenous folate from an albumin preparation, the process comprising:
providing an aqueous albumin solution containing endogenous folate;
contacting the aqueous albumin solution with a mixture of anion and cation exchange resins to create a reaction mixture;
monitoring the pH of the reaction mixture; and
separating the exchange resins from the reaction mixture to form a supernatant fraction when the pH of the reaction mixture is at an initiation pH sufficient to initiate separation of folic acid from the reaction mixture.
2. The process of claim 1 , wherein the aqueous albumin solution comprises human serum albumin.
3. The process of claim 1 , wherein the aqueous albumin solution comprises bovine serum albumin.
4. The process of claim 1 , wherein the initiation pH is between about 3.5 and about 5.0.
5. The process of claim 1 , wherein the initiation pH is between about 4.0 and about 5.0.
6. The process of claim 1 , further comprising maintaining the pH of the supernatant fraction at the initiation pH for a period of time.
7. The process of claim 1 , further comprising adjusting the pH of the supernatant faction to a use pH that is between about 7.0 and about 8.0.
8. The process of claim 1 , wherein the resulting albumin preparation has a folate concentration between 0 and about 1.0 ng/ml.
9. A process for removing endogenous Vitamin B12 from an albumin preparation, the process comprising:
providing an aqueous albumin solution comprising endogenous Vitamin B12;
contacting the aqueous albumin solution with a mixture of anion and cation exchange resins to create a reaction mixture;
monitoring the pH of the reaction mixture;
separating the exchange resins from the reaction mixture to form a supernatant fraction when the pH of the reaction mixture is between about 3.5 and about 5.0.
10. The process of claim 9 , wherein the aqueous albumin solution comprises human serum albumin.
11. The process of claim 9 , wherein the aqueous albumin solution comprises bovine serum albumin.
12. The process of claim 9 , wherein the step of separating the exchange resins from the reaction mixture to form a supernatant fraction is initiated when the pH of the reaction mixture is between about 4.0 and about 5.0.
13. The process of claim 9 , further comprising maintaining the pH of the supernatant fraction for a period of time.
14. The process of claim 9 , further comprising adjusting the pH of the supernatant faction to a use pH that is between about 7.0 and about 8.0.
15. A method of determining an analyte in a test sample suspected of containing the analyte, the method comprising:
performing an immunoassay technique using a reference control comprising an albumin preparation having a concentration of Vitamin B12 between 0 and about 50 pg/ml and a concentration of folate between 0 and about 1.0 ng/ml.
16. The method of claim 15 , wherein the immunoassay technique comprises a Luminescent Oxygen Channeling Immunoassay.
17. A kit for use in an assay for determining an analyte in a test sample, comprising:
a first albumin preparation having a concentration of Vitamin B12 between 0 and about 50 pg/ml;
a second albumin preparation containing a predetermined concentration of Vitamin B12 that is greater than the concentration of Vitamin B12 of the first albumin preparation; and
further comprising a photochemically activatable chemiluminescent compound.
18. A kit for use in an assay for determining an analyte in a test sample, comprising:
a first albumin preparation having a concentration of folate between 0 and about 1.0 ng/ml;
a second albumin preparation containing a predetermined concentration of folate that is greater than the concentration of folate of the first albumin preparation; and
a photoactivatable chemiluminescent compound.
19. The kit of claim 18 , further comprising a third albumin preparation containing a second predetermined concentration of folate that is greater than the predetermined concentration of folate of the second albumin preparation.
20. The kit of claim 18 , further comprising a member of a specific binding pair that is able to specifically bind folate and a folate analog.
21. The kit of claim 18 , further comprising a folate analog.
22. The kit of claim 17 , further comprising a Vitamin B12 analog.
23. The kit of claim 17 , further comprising a member of a specific binding pair that is able to specifically bind Vitamin B12.